Durham company Aerie Pharmaceuticals Inc. (AERI:NMQ) working in Pharmaceuticals and Biotechnology sees value fall 45.7% in week ending Sept. 10

0Comments

Value in Pharmaceuticals and Biotechnology stocks rose 3.9 percent in the week ending Sept. 10 from the previous week.

The strongest performing Pharmaceuticals and Biotechnology company in North Carolina was CbdMD Inc. (YCBD:ASQ), sitting 616.7 percent higher to sell at $0.2894.

Tenax Therapeutics Inc. (TENX:NAQ) fared the worst among North Carolina companies, suffering an 80.1 percent drop to $0.2.

Among Durham companies, Novan Inc. (NOVN:NAQ) saw the highest rise in value of 176.6 percent in the week ending Sept. 10.

The Life Insurance industry was the week’s best-performing industry on the market. The market is divided into 45 different industries.

Finance and Credit Services was the worst-performing industry.

Healthcare and technology stocks are viewed as the safest bets for long-term gains.

Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, suggesting that they are generally a stable investment.

While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.

For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.

Nothing in this article is to be assumed as financial advice.

Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.

Rank of stock market industries in week ending Sept. 10

Industry Percentage Change Highest Positive Change Largest Negative Change
Life Insurance 14.5% 710.1% -41.3%
Construction and Materials 10.2% 1,154.4% -96.9%
Tobacco 9.6% 256.5% -32.5%
Medical Equipment and Services 9.2% 13,893.5% -94.8%
Alternative Energy 8.4% 366.8% -43.5%
Industrial Metals and Mining 8% 768.8% -95.5%
Software and Computer Services 7.9% 3,833.1% -99.1%
Industrial Engineering 6.4% 474% -99.9%
Retailers 5.3% 926% -76.9%
Chemicals 5.1% 575% -55.2%
Electronic and Electrical Equipment 4.9% 929.6% -92.1%
Personal Goods 4.7% 860.8% -82.7%
Industrial Support Services 4.3% 4,254.4% -79%
General Industrials 4.2% 316.9% -39.8%
Pharmaceuticals and Biotechnology 3.9% 7,352.6% -96.4%
Precious Metals and Mining 3.9% 100% -99.3%
Travel and Leisure 3.9% 2,069.1% -88.4%
Household Goods and Home Construction 3.9% 4,522.9% -94.3%
Real Estate Investment Trusts 3.8% 1,067.1% -97.2%
Waste and Disposal Services 3.6% 285% -94.4%
Leisure Goods 3.5% 421.4% -96.1%
Industrial Transportation 3.4% 5,503.6% -59.9%
Electricity 3.1% 81.2% -52.5%
Aerospace and Defense 3.1% 523.2% -69.1%
Telecommunications Equipment 3.1% 405.6% -56.8%
Personal Care, Drug and Grocery Stores 2.9% 323.4% -81%
Consumer Services 2.9% 29,661.9% -95.8%
Automobiles and Parts 2.9% 382.1% -69.3%
Media 2.7% 163,698.1% -76.1%
Mortgage Real Estate Investment Trusts 2.5% 312.5% -62.7%
Real Estate Investment and Services 2.4% 8,524.2% -98.1%
Gas, Water and Multi-utilities 2.3% 490.2% -52.4%
Industrial Materials 2.3% 181.4% -51.5%
Health Care Providers 1.8% 673.9% -70.6%
Technology Hardware and Equipment 1.7% 236.9% -52.8%
Non-life Insurance 1.6% 6,191.5% -79.6%
Investment Banking and Brokerage Services 0.7% 2,331.2% -99.4%
Closed End Investments 0.5% 2,633.8% -95.1%
Banks 0.4% 689,978.4% -99.9%
Oil, Gas and Coal 0.3% 45,749.6% -99%
Open End and Miscellaneous Investment Vehicles -0.1% 1,277,363.8% -99.9%
Food Producers -1.1% 2,168.4% -97.7%
Telecommunications Service Providers -2% 3,069.5% -88.9%
Beverages -17.4% 370.3% -78.2%
Finance and Credit Services -56.2% 608.9% -46.5%


Related

Craig T. Albanese, CEO

Duke Health trial finds immunotherapy delays chemotherapy in advanced colorectal cancer

A new clinical trial from Duke Health shows that first-line immunotherapy may delay or replace chemotherapy in advanced colorectal cancer cases. The findings offer hope for improved quality of life among younger patients facing aggressive forms of the disease.

Hannah Lohman, RTI Research Environmental Engineer

EPA and HHS announce actions to address microplastics in drinking water

The EPA and HHS have announced new efforts targeting microplastics in U.S. drinking water systems. RTI International staff attended as federal officials detailed regulatory plans prioritizing research funding into detection methods, impacts on health, prevention strategies, and laboratory standards.

Tim J. Gabel, President and Chief Executive Officer

RTI International examines trends and shifts in ultra-processed food consumption

RTI International highlights rising consumer awareness about ultra-processed foods (UPFs) alongside industry reformulations and emerging state-level policies restricting certain additives. The organization points out challenges surrounding inconsistent definitions while noting increased calls for transparency from both regulators and public health advocates.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Durham Reporter.